STEMETIL prochlorperazine mesilate 12.5 mg/mL Injection ampoule (export)

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

prochlorperazine mesilate, Quantity: 12.5 mg/mL

Commercializzato da:

Sanofi-Aventis Australia Pty Ltd

INN (Nome Internazionale):

prochlorperazine mesilate

Forma farmaceutica:

Injection

Composizione:

Excipient Ingredients: sodium metabisulfite; monoethanolamine; sodium sulfite; water for injections; sodium chloride

Via di somministrazione:

Intramuscular

Confezione:

10 x 1 mL

Tipo di ricetta:

(S1) This Schedule is intentionally blank

Indicazioni terapeutiche:

STEMETIL is used in vertigo due to Meniere?s syndrome, labyrinthitis and other causes, and for nausea and vomiting from whatever cause. It may also be used for migraine, schizophrenia (particularly in the chronic stage), acute mania and as an adjunct to the short term management of anxiety.

Dettagli prodotto:

Visual Identification: Clear solution, almost colourless or not more than very pale yellow.; Container Type: Ampoule; Container Life Time: 5 Years; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2007-07-16